Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-339.67M
↓ 231% below average
Average (9y)
$-102.62M
Historical baseline
Range
High:$26.22M
Low:$-339.67M
CAGR
+36.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-339.67M | -47.7% |
| 2023 | $-229.95M | -51.5% |
| 2022 | $-151.76M | -678.8% |
| 2021 | $26.22M | +136.7% |
| 2020 | $-71.42M | -24.1% |
| 2019 | $-57.54M | +24.2% |
| 2018 | $-75.88M | -22.5% |
| 2017 | $-61.95M | -41.6% |
| 2016 | $-43.77M | -113.4% |
| 2015 | $-20.51M | - |